Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$95.27 - $108.47 $35,916 - $40,893
377 Added 11.4%
3,685 $356,000
Q4 2023

Jan 29, 2024

BUY
$92.27 - $101.54 $305,229 - $335,894
3,308 New
3,308 $334,000
Q3 2020

Nov 25, 2020

SELL
$82.14 - $91.0 $383,840 - $425,243
-4,673 Closed
0 $0
Q2 2020

Jul 23, 2020

SELL
$80.93 - $91.1 $24,279 - $27,330
-300 Reduced 6.03%
4,673 $408,000
Q1 2020

Apr 17, 2020

SELL
$70.67 - $99.01 $38,373 - $53,762
-543 Reduced 9.84%
4,973 $410,000
Q4 2019

Jan 28, 2020

SELL
$84.35 - $95.37 $465,274 - $526,060
-5,516 Closed
0 $0
Q4 2019

Jan 28, 2020

BUY
$84.35 - $95.37 $465,274 - $526,060
5,516 New
5,516 $525,000
Q3 2019

Oct 25, 2019

BUY
$85.54 - $94.26 $61,674 - $67,961
721 Added 15.04%
5,516 $479,000
Q1 2019

Apr 30, 2019

BUY
$75.32 - $86.15 $144,162 - $164,891
1,914 Added 66.44%
4,795 $459,000
Q4 2018

Jan 29, 2019

BUY
$73.66 - $82.02 $212,214 - $236,299
2,881 New
2,881 $247,000
Q3 2018

Nov 05, 2018

SELL
$66.94 - $77.43 $76,847 - $88,889
-1,148 Closed
0 $0
Q2 2018

Aug 09, 2018

BUY
$64.91 - $73.36 $74,516 - $84,217
1,148 New
1,148 $87,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Bay Colony Advisory Group, Inc D Portfolio

Follow Bay Colony Advisory Group, Inc D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

News

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.